WEBULL
WebtradeDownload

Does Earnings Beat Change The Bull Case For SCOR Stock (ENXTPA:SCR)?

Simply Wall St · 2d ago
  • SCOR SE reported third quarter 2026 net income of €206 million and nine-month net income of €603 million, both slightly lower than the prior year, with all business segments contributing and an estimated Group solvency ratio of 221% at the end of the period.
  • The reinsurer combined an 84.1% P&C combined ratio in an active catastrophe quarter with stronger life and health and investment contributions. Together, these supported earnings that came in above analyst expectations and underpinned management's confidence as it prepares a new plan beyond its Forward 2026 program.
  • We will now examine how SCOR's stronger than expected profit and higher solvency ratio could reshape the investment narrative for the group.

Scan how SCOR's earnings resilience compares with other insurers by reviewing our curated list of solid balance sheet and fundamentals (203 results).

SCOR Investment Narrative Recap

To own SCOR, you need to be comfortable with a reinsurer that relies on underwriting discipline, a strong solvency position and steady Life & Health and investment earnings rather than rapid expansion. The latest results show slightly softer net income but still broad based profit, with P&C absorbing an active catastrophe quarter and the solvency ratio estimated at 221%.

The key short term swing factor remains whether P&C margins can hold, as management anticipates a 2 percentage point deterioration in the combined ratio as 2026 underwriting earns through. The main risk is pressure on pricing or claims volatility, while the Q3 numbers do not materially alter that near term equation.

The fresh catalyst in focus is the third quarter 2026 earnings release itself. SCOR reported €206 million of net income for the quarter and €603 million for the first nine months, slightly below the prior year in both periods. Earnings were supported by all business lines, with the 84.1% P&C combined ratio and stronger Life & Health and investment income doing the heavy lifting.

For you as a shareholder, that update links directly to the existing catalysts. It reinforces the story around balance sheet strength, with solvency at 221%, and around the Life & Health pivot and investment portfolio repositioning. It also sets the stage for the new plan to be presented in December, where management execution on underwriting discipline, capital deployment and legal dispute outcomes will likely be central to the risk reward debate.

SCOR's current analyst narrative points to €17.0b of revenue and €857.2 million of earnings by 2029, based on 3.8% yearly revenue growth and an earnings increase of about €34.2 million from €823.0 million today.

Uncover why SCOR's fair value indicates a 4% potential upside to its current price. This opportunity could narrow quickly.

ENXTPA:SCR 1-Year Stock Price Chart
ENXTPA:SCR 1-Year Stock Price Chart

Exploring Other Perspectives

Fair value views on SCOR from the Simply Wall St Community span roughly €36 to almost €94 a share across 2 separate submissions, so retail opinions already cover deep discount to rich pricing scenarios. You also have rising reinsurance demand, P&C competition and unresolved Covéa disputes that could all shift how future earnings power is judged.

Explore another SCOR fair value estimate, including one that suggests it could be worth just €36.02.

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider forming your own view.

Looking For More Ideas Beyond SCOR?

If SCOR has sharpened your thinking about risk, capital strength and earnings quality, it can be useful to compare it with other listed businesses that share some of those traits. The Simply Wall St Screener lets you quickly filter the market to match the kind of trade off between resilience, income and upside that fits your own approach.

  • If you want potential upside with strict balance sheet standards, scan a curated 603 high quality undiscovered gems that already clear tough quality and fundamentals checks.
  • If capital preservation comes first for you, narrow the field to 218 resilient stocks with low risk scores that score well on resilience so you can focus on sturdier profiles.
  • If regular income is a priority, line up higher yielding opportunities through a focused set of 221 dividend fortresses that aim for yield alongside stability.